Coen Stacy Ann's Form 4 filing
ImmunoGen, Inc. (IMGN) · filed Aug 4, 2023
- Accession no.
- 0001415889-23-011882
- Filed
- Aug 4, 2023
- Trade date
- Aug 2-4, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.45M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coen Stacy AnnCIK 0001814150 | Officer (SVP & CHIEF BUSINESS OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2023 | Common Stock | MOption exerciseAcquired | +4,255 | $4.92 | +$20,934.6 | 15,215 | Direct | |
| Aug 2, 2023 | Common Stock | SSaleDisposed | −4,255 | $18.12 | −$77,100.6 | 10,960 | Direct | |
| Aug 4, 2023 | Common Stock | MOption exerciseAcquired | +80,326 | $4.92 | +$395,203.92 | 91,286 | Direct | |
| Aug 4, 2023 | Common Stock | SSaleDisposed | −80,326 | $17.05 | −$1,369,558.3 | 10,960 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2023 | Common Stock | MOption exerciseDisposed | −4,255 | $0.00 | $0 | 255,745 | Direct | |
| Aug 4, 2023 | Common Stock | MOption exerciseDisposed | −80,326 | $0.00 | $0 | 175,419 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.